Molecular pathogenesis of bile formation and cholestatic diseases;Mécanismes moléculaires de la formation de la bile et des maladies cholestatiques

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 7, 2003, Pages 1261-1276

  Poupon, Raoul ^a,b   Bourel, Michel ^c   Ardaillou, Raymond ^c   Larcan, Alain ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c NONE

Author keywords

Bile acids and salts; Cholestasis; Cholest rol; Cytoplasmic and nuclear; Genetics; Inflammation; Receptors; Xenobiotics

Indexed keywords

BILE ACID; CHOLESTEROL; URSODEOXYCHOLIC ACID; XENOBIOTIC AGENT; CHOLAGOGUE;

ACTIVE TRANSPORT; ARTICLE; BILE ACID SYNTHESIS; BILE SECRETION; BILIARY TRACT DRAINAGE; CHOLESTASIS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; HUMAN; INTRAHEPATIC BILE DUCT; LIPID METABOLISM; LIVER DISEASE; LIVER GRAFT; PATHOGENESIS; PHENOTYPIC VARIATION; TRANSCRIPTION REGULATION; BILE; CELL MEMBRANE; GENETIC TRANSCRIPTION; HOMEOSTASIS; INFLAMMATION; INTRAHEPATIC CHOLESTASIS; OSMOSIS; PATHOPHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

BILE; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; HOMEOSTASIS; HUMANS; INFLAMMATION; LIPID METABOLISM; OSMOSIS; TRANSCRIPTION, GENETIC; URSODEOXYCHOLIC ACID; XENOBIOTICS;

EID: 2442719376     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33908-1     Document Type: Article

References (51)

1. JANSEN P.L. - Foreword : from classic bile physiology to cloned transporters. Semin Liver Dis 2000, 20, 245-250.
2. MEIER P.J., STIEGER B. - Bile salt transporters. Annu Rev Physiol 2002, 64, 635-661.
3. TRAUNER M., MEIER P.J., BOYER J.L. - Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339, 1217-1227.
4. CHAUWLA A., REPA J.J., EVANS R.M., MANGELSDORF D.J. - Nuclear receptors and lipid physiology : opening the X-files. Science 2001, 294, 1866-1870.
5. OLEFSKY J.M. - A unified nomenclature system for the nuclear receptor superfamily. Cell 1999, 97, 161-163.
6. OFEFSKY J.M. - Nuclear receptor minireview series. J Biol Chem 2001, 276, 36863-36864.
7. KARFEN S.J. - Nuclear receptor regulation of hepatic function. J Hepatol 2002, 36, 832-850.
8. MAKISHIMA M., OKAMOTO A.Y., REPA J.J., TU H., LEARNED R.M., LUL A. - Identification of a nuclear receptor for bile acids. Science 1999, 284, 1362-1365.
9. KAST H.R., NGUYEN C.M., SINAL C.J., JONES S.A., LAFFITTE B.A., REUE K. - Farnesoid X-activated receptor induces apolipoprotein C-II transcription : a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 2001, 15, 1720-1728.
10. SINAL C.J., TOHKIN M., MIYATA M., WARD J.M., LAMBERT G., GONZALEZ F.J. - Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102, 731-744.
11. XIE W., RADOMINSKA-PANDYA A., SHI Y., SIMON C.M., NELSON M.C., ONG E.S. - An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A 2001, 98, 3375-3380.
12. STAUDINGER J., LIU Y., MADAN A., HABEEBU S., KLAASSEN C.D. - Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 2001, 29, 1467-1472.
13. STAUDINGER J.L., GOODWIN B., JONES S.A., HAWKINS-BROWN D., MACKENZIE K.I., LATOUR A. - The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 2001, 98, 3369-3374.
14. KLIEWER S.A., WILLSON T.M. - Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 2002, 43, 359-364.
15. SYNOLD T.W., DUSSAULT I., FORMAN B.M. - The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 2001, 7, 584-590.
16. SCHUETZ E.G., STROM S., YASUDA K., LECUREUR V., ASSEM M., BRIMER C. - Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 2001, 276, 39411-39418.
17. XIE W., YEUH M.F., RADOMINSKA-PANDYA A., SAINI S.P., NEGISHI Y., BOTTROFF B.S. - Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A 2003 ; 700, 4150-4155.
18. FU X., MENKE J.G., CHEN Y., ZHOU G., MACNAUL K.L., WRIGHT S.D. - 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001, 276, 38378-38387.
19. PEET D.J., TURLEY S.D., MA W., JANOWSKI B.A., LOBACCARO J.M., HAMMER R.E. -Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93, 693-704.
20. SONG C., HIIPAKKA R.A., LIAO S. - Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000, 65, 423-427.
21. REPA J.J., MANGELSDORF D.J. - The liver X receptor gene team : potential new players in atherosclerosis. Nat Med 2002, 8, 1243-1248.
22. WITTENBURG H., CAREY M.C. - Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8. J Clin Invest 2002, 110, 605-609.
23. GRAF G.A., LI W.P., GERARD R.D., GELISSEN I., WHITE A., COHEN J.C. - Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002, 110, 659-669.
24. Yu L., LI-HAWKINS J., HAMMER R.E., BERGE K.E., HORTON J.D., COHEN J.C. -Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002, 110, 671-680.
25. JACQUEMIN E., HADCHOUEL M. - Genetic basis of progressive familial intrahepatic cholestasis. J Hepatol 1999, 31, 377-381.
26. JANSEN P.L., MULLER M. - The molecular genetics of familial intrahepatic cholestasis. Gut 2000, 47, 1-5.
27. ROSMORDUC O., HERMELIN B., POUPON R. - MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001, 120, 1459-1467.
28. GIRODON E., STERNBERG D., CHAZOUILLERES O., CAZENEUVE C., HUOT D., CALMUS Y. - Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with sclerosing cholangitis. J Hepatol 2002, 37, 192-197.
29. BOHAN A., BOYER J.L. - Mechanisms of hepatic transport of drugs : implications for cholestatic drug reactions. Semin Liver Dis 2002, 22, 123-136.
30. LEE J., BOYER J.L. - Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000, 20, 373-384.
31. LEE J., AZZAROLI F., WANG L., SOROKA C.J., GIGLIOZZI A., SETCHELL K.D. - Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001, 121, 1473-1484.
32. ZOLLNER G., FICKERT P., ZENZ R., FUCHSBICHLER A., STUMPTNER C., KENNER L. - Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001, 33, 633-646.
33. PHILLIPS M.J., POUCELL S., ODA M. - Mechanisms of cholestasis. Lab Invest 1986, 54, 593-608.
34. FALLON M.B., BRECHER A.R. BALDA M.S., MATTER K. ANDERSON J.M. - Altered hepatic localization and expression of occludin after common bile duct ligation. Am J Physiol 1995, 269, C1057-C1062.
35. MARKS D.L., LARUSSO N.F., MC NIVEN M.A. - Isolation of the microtubule-vesicle motor kinesin from rat liver : Selective inhibition by cholestatic bile acids. Gastroenterology 1995, 108, 824-833.
36. BEUERS U., NATHANSON M.H., ISALES C.M., BOYER J.L. - Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. J Clin Invest 1993, 92, 2984-2993.
37. FALLON M.B., NATHANSON M.H., MENNONE A., SAEZ J.C., BURGSTAHLER A.D., ANDERSON J.M. - Altered expression and function of hepatocyte gap junctions after common bile duct ligation in the rat. Am J Physiol 1995, 268, C1186-C1194.
38. POUPON R., CHRÉTIEN Y., POUPON R.E., BALLET F., CALMUS Y., DARNIS F. - "Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis ? " Lancet 1987, 8537, 834-836.
39. POUPON R.E., BALKAU B., ESCHWEGE E., POUPON R. - A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC study Group. N Engl J Med, 1991, 524, 1548-1854.
40. POUPON R.E., POUPON R., BALKAU B. - Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 1994, 330, 1342-1347.
41. POUPON R.E., LINDOR K.D., CAUCH-DUDEK K., DICKSON E.R., POUPON R., HEATHCOTE E.J. - Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997, 113, 884-890.
42. POUPON R., POUPON R.E. - Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 1995 ; 66, 1-15.
43. PAUMARTNER G., BEUERS U. - Ursodeoxycholic acid in cholestatic liver disease : mechanisms of action and therapeutic use revisited. Hepatology 2002, 36, 525-531.
44. RODRIGUES C.M., FAN G., WONG P.Y., KREN B.T, STEER C.J. - Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998 ; 4, 165-178.
45. RODRIGUES C.M., FAN G., MA X., KREN B.T., STEER C.J. - A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998 ; 101, 2790-2799.
46. KURZ A.K., GRAF D., SCHMITT M., VOM DAHL S., HAUSSINGER D. -Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 2001, 121, 407-419.
47. BEUERS U., BILZER M., CHITTATTU A., KULLAK-UBLICK G.A., KEPPLER D., PAUMGARTNER G. - Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 2001, 33, 1206-1216.
48. SONODA J., XIE W., ROSENFELD J.M., BARWICK J.L., GUZELIAN P.S., EVANS R.M. -Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A 2002, 99, 13801-13806.
49. WEI P., ZHANG J., EGAN-HAGLEY M., LIANG S., MOORE D.D. - The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000, 407, 920-3.
50. ZHANG J., HUANG W., CHUA S.S., MOORE D.D. - Modulation of acetaminophen toxicity by the xenobiotic receptor CAR. Science 2002, 298 : 422-4.
51. HUANG W., ZANG J., CHUA S.S., QATANI M., HAN Y., GREANATA R., MOORE D.D. - Induction of bilirubin clearance by the constitutive androstane receptor (CAR). PNAS 2003, 100, 4156-61.